Kenneth H Hu

13PUBLICATIONS
103CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 25, 2026
Local gene editing of fibroblasts in tumors reveals a new cancer-associated fibroblast state.

Nicholas F Kuhn, Itzia Zaleta-Linares, Kenneth H Hu

|Feb 23, 2026
Spatial immune hubs defined by conserved activated dendritic cells are remodeled by immunotherapy.

Tomoyuki Minowa, Sunita Keshari, Shan He

|Jan 09, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

|Nov 24, 2025
Bhlhe40 Coordinates T Cell Programs with Distinct CD4 and CD8 T Cell Requirements for Anti-PD-1 Versus Anti-CTLA-4.

Akata Saha, Tomoyuki Minowa, Alexander S Shavkunov

|Jul 11, 2025
Multimodal delineation of a layer of effector function among exhausted CD8 T cells in tumors.

Arja Ray, Molly Bassette, Kenneth H Hu

|Apr 01, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response.

Miho Tanaka, Lotus Lum, Kenneth H Hu

Pageof 3